| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 2158753C7E |
| InChI Key | WANIDIGFXJFFEL-SANMLTNESA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C27H22F4N6O3S |
| Molecular Weight | 586.57 |
| AlogP | 4.06 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 102.98 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 41.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Glucocorticoid receptor antagonist | Other |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C19
|
- | 8000 | - | - | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C8
|
- | 210 | - | - | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C9
|
- | 2000 | - | - | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2D
Cytochrome P450 2D6
|
- | 9000 | - | - | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | 1300 | - | - | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A5
|
- | 4900 | - | - | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 1
|
- | - | - | 7-81 | 100 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Adrenocortical Hyperfunction | 3 | D000308 | ClinicalTrials |
| Carcinoma, Pancreatic Ductal | 3 | D021441 | ClinicalTrials |
| Cushing Syndrome | 3 | D003480 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Fallopian Tube Neoplasms | 2 | D005185 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
| Adrenal Cortex Neoplasms | 1 | D000306 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1496510-51-0 |
| ChEMBL | CHEMBL4068611 |
| DrugBank | DB14976 |
| FDA SRS | 2158753C7E |
| PubChem | 73051463 |
| SureChEMBL | SCHEMBL15454999 |
| ZINC | ZINC000141949519 |